Reference: BioNTech Manufacturing GmbH. (2022). COVID-19 mRNA vaccine (nucleoside modified) Reporting Period Periodic Safety Update Report (PSUR) 3: 19 December 2021 through 18 June 2022. Summary: The third Periodic Safety Update Report (PSUR) for the COVID-19 mRNA vaccine (BNT162b2), also known as COMIRNATY®, covers data from 19 December 2021 to 18 June 2022. It outlines […]
Reference: Palmer, M., & Bhakdi, S. (2022). Vascular and organ damage induced by mRNA vaccines: Irrefutable proof of causality. doctors4covidethics.org. Summary: This article by Palmer and Bhakdi presents alarming findings regarding the safety of mRNA vaccines, particularly in relation to COVID-19. The authors argue that mRNA vaccines do not remain at the injection site but
Reference: Palmer, M., & Bhakdi, S. (2022). Vascular and organ damage induced by mRNA vaccines: Irrefutable proof of causality. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi presents compelling evidence regarding the adverse effects of mRNA vaccines, particularly focusing on their widespread distribution and subsequent impact on organ health. Key findings reveal that mRNA vaccines
Reference: Rancourt, D. G., Baudin, M., & Mercier, J. (2022). COVID-Period Mass Vaccination Campaign and Public Health Disaster in the USA: From age/state-resolved all-cause mortality by time, age-resolved vaccine delivery by time, and socio-geo-economic data. Preprint. Retrieved from https://www.medrxiv.org/ Summary: This article examines the impact of the COVID-19 vaccination campaign on all-cause mortality in the
Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(5), 649-659. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article assesses serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) through a
Reference: South African National Department of Health. (2022). Rapid review report for COVID-19 vaccine 5–11-year-old children: Should the BNT162b2 COVID-19 vaccine be used for children aged 5 -11 years old in South Africa. Summary: A rapid review evaluated the efficacy and safety of the BNT162b2 COVID-19 vaccine for children aged 5-11 in South Africa. The
Reference: Kruse, P. (2022). Swissmedic criminal claim – Executive summary. K R U S E | L A W. Retrieved from https://coronacomplaint.ch/ Summary: The article details a criminal claim involving 37 complainants and six private claimants against Swissmedic regarding the mRNA vaccines. It asserts that the administration of these vaccines poses a significant health risk,
Reference: Pfizer. (2022). Cumulative and interval summary tabulation of serious and non-serious adverse reactions from post-marketing data sources BNT162B2. Summary: The document presents a comprehensive analysis of cumulative and interval data on serious and non-serious adverse reactions associated with the BNT162B2 vaccine up to June 18, 2022. It details a total of 1,485,027 cases cumulatively,
Reference: Unknown. (2022). SA VAERS: An independent alternative vaccine adverse events reporting system. Retrieved from https://savaers.co.za/ Summary: SA VAERS is an independent vaccine adverse events reporting system aimed at providing a platform for survivors and victims of negative effects from the COVID-19 vaccine. Managed by Transformative Health Justice, the system focuses on enhancing data transparency